| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.082 | 0.08 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.046 | 0.3 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.044 | 0.4 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.044 | 0.4 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.041 | 0.4 |